Your browser doesn't support javascript.
loading
Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang, Yu; Chikata, Takayuki; Kuse, Nozomi; Murakoshi, Hayato; Gatanaga, Hiroyuki; Oka, Shinichi; Takiguchi, Masafumi.
Affiliation
  • Zhang Y; Division of International Collaboration Research and Tokyo Joint Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
  • Chikata T; Division of International Collaboration Research and Tokyo Joint Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
  • Kuse N; Division of International Collaboration Research and Tokyo Joint Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
  • Murakoshi H; Division of International Collaboration Research and Tokyo Joint Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
  • Gatanaga H; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Oka S; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Takiguchi M; Division of International Collaboration Research and Tokyo Joint Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
J Virol ; 96(22): e0124822, 2022 11 23.
Article in En | MEDLINE | ID: mdl-36326273
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV Seropositivity Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Virol Year: 2022 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV Seropositivity Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Virol Year: 2022 Document type: Article Affiliation country: Japón